SCHAFFER DERACE L

Average Profitability
<0.0001%
Insider Buys Quantity
41
Insider Buys Sum
$5.49M
Insider Sells Quantity
14
Insider Sells Sum
$5.21M

Insider Activity of SCHAFFER DERACE L

The largest purchase of all time was on 2007-08-03 and amounted to 200000 shares of Altimmune, Inc. for $1.51M.

The largest sale of all time was on 2011-05-19 and amounted to 284994 shares of Altimmune, Inc. for $1.05M.

Biography of SCHAFFER DERACE L

No biography is available at this moment.

2019-06-05SaleLantheus Holdings, Inc.
LNTH
director
20,000
0.0502%
$24.71$494,254-21.84%
2019-06-04SaleLantheus Holdings, Inc.
LNTH
director
20,000
0.0504%
$24.17$483,318-19.05%
2019-06-03SaleLantheus Holdings, Inc.
LNTH
director
20,000
0.0516%
$23.47$469,450-14.06%
2019-04-01SaleLantheus Holdings, Inc.
LNTH
director
20,000
0.0514%
$24.41$488,188-11.87%
2017-12-29PurchaseAltimmune, Inc.
ALT
director
38,699
0.1865%
$1.93$74,778-75.73%
2017-12-28PurchaseAltimmune, Inc.
ALT
director
58,711
0.2913%
$1.92$112,672-73.85%
2017-12-27PurchaseAltimmune, Inc.
ALT
director
77,706
0.3837%
$1.77$137,210-71.66%
2017-12-26PurchaseAltimmune, Inc.
ALT
director
51,442
0.2646%
$1.81$93,269-71.14%
2017-12-22PurchaseAltimmune, Inc.
ALT
director
17,982
0.0902%
$1.61$28,877-67.99%
2017-12-07PurchaseAltimmune, Inc.
ALT
director
15,278
0.0738%
$1.74$26,616-70.11%
2017-12-06PurchaseAltimmune, Inc.
ALT
director
32,212
0.159%
$1.80$57,991-70.17%
2017-12-05PurchaseAltimmune, Inc.
ALT
director
26,990
0.1287%
$1.78$47,975-70.54%
2017-12-04PurchaseAltimmune, Inc.
ALT
director
14,600
0.0736%
$1.81$26,391-69.28%
2017-12-01PurchaseAltimmune, Inc.
ALT
director
10,430
0.0519%
$1.80$18,809-69.28%
2017-11-30PurchaseAltimmune, Inc.
ALT
director
25,956
0.1306%
$1.84$47,632-69.28%
2017-11-29PurchaseAltimmune, Inc.
ALT
director
15,884
0.0791%
$1.94$30,755-71.01%
2017-11-28PurchaseAltimmune, Inc.
ALT
director
24,790
0.1251%
$1.97$48,891-71.13%
2017-11-27PurchaseAltimmune, Inc.
ALT
director
20,084
0.1006%
$2.00$40,120-71.46%
2017-11-24PurchaseAltimmune, Inc.
ALT
director
13,010
0.0634%
$2.02$26,323-72.04%
2017-11-22PurchaseAltimmune, Inc.
ALT
director
10,522
0.0528%
$2.10$22,121-71.92%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.